(Q34288593)

English

Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational s

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational s (English)

1 reference

Europe PubMed Central

1 August 2017

Cornelia Lass-Florl

2

object named as

Cornelia Lass-Flörl

1 reference

Europe PubMed Central

1 August 2017

author name string

Jutta Auberger

1

1 reference

Europe PubMed Central

1 August 2017

Maria Aigner

3

1 reference

Europe PubMed Central

1 August 2017

Johannes Clausen

4

1 reference

Europe PubMed Central

1 August 2017

Günther Gastl

5

1 reference

Europe PubMed Central

1 August 2017

David Nachbaur

6

1 reference

Europe PubMed Central

1 August 2017

language of work or name

0 references

publication date

30 May 2012

1 reference

Europe PubMed Central

1 August 2017

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

1 August 2017

67

1 reference

Europe PubMed Central

1 August 2017

9

1 reference

Europe PubMed Central

1 August 2017

2268-2273

1 reference

Europe PubMed Central

1 August 2017

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

How I treat mucormycosis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Newer systemic antifungal agents : pharmacokinetics, safety and efficacy

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Optimising absorption of posaconazole.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

The effect of gastric Acid on the absorption of posaconazole

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Therapeutic drug monitoring of voriconazole and posaconazole

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Posaconazole therapeutic drug monitoring: a reference laboratory experience

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Pharmacokinetics and safety of oral posaconazole in neutropenic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Exposure-response of posaconazole used for prophylaxis against invasive fungal infections: evaluating the need to adjust doses based on drug concentrations in plasma

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Invasive fungal disease in patients treated for newly diagnosed acute leukemia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Airborne fungus exposure prior to hospitalisation as risk factor for mould infections in immunocompromised patients.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Prospective evaluation of Candida species colonization in hospitalized cancer patients: impact on short-term survival in recipients of marrow transplantation and patients with hematological malignancies.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Evaluation of the Abbott Real-Time HIV-1 quantitative assay with dried blood spot specimens

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Effect of pH and Comedication on Gastrointestinal Absorption of Posaconazole

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS189

21 January 2018

Identifiers

10.1093/JAC/DKS189

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34288593&oldid=1623932699"